Amkay Products

₹51 1.9 | 3.9%

WEBSITE BSE:544169 NSE : AMKAY 08 Jul, 11:19

Market Cap ₹44 Cr.

Stock P/E 16.8

P/B 2

Current Price ₹51

Book Value ₹ 26.1

Face Value 10

52W High ₹86.5

Dividend Yield 0%

52W Low ₹ 36

Edit Ratio

Amkay Products Research see more...

Overview Inc. Year: 2007Industry: Medical Equipment/Supplies/Accessories

Amkay Products Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Amkay Products Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Amkay Products Profit & Loss

#(Fig in Cr.)	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Net Sales	41	37	28	31
Other Income	0	0	0	1
Total Income	41	37	28	32
Total Expenditure	36	34	25	28
Operating Profit	5	3	4	5
Interest	0	0	0	1
Depreciation	0	1	1	1
Exceptional Income / Expenses	0	0	0	0
Profit Before Tax	4	2	2	4
Provision for Tax	1	1	1	1
Profit After Tax	3	1	2	3
Adjustments	0	0	0	0
Profit After Adjustments	3	1	2	3
Adjusted Earnings Per Share	4.9	2.3	2.4	4.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	11%	-9%	0%	0%
Operating Profit CAGR	25%	0%	0%	0%
PAT CAGR	50%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-35%	NA%	NA%	NA%
ROE Average	30%	26%	36%	36%
ROCE Average	29%	28%	39%	39%

Amkay Products Balance Sheet

#(Fig in Cr.)	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	5	6	8	10
Minority's Interest	0	0	0	0
Borrowings	1	3	3	1
Other Non-Current Liabilities	-0	-0	0	-0
Total Current Liabilities	8	6	5	7
Total Liabilities	14	16	16	18
Fixed Assets	2	4	3	3
Other Non-Current Assets	1	2	4	3
Total Current Assets	10	10	9	12
Total Assets	14	16	16	18

Amkay Products Cash Flow

#(Fig in Cr.)	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	0	1	0	0
Cash Flow from Operating Activities	3	-0	1	-1
Cash Flow from Investing Activities	-2	-3	-1	0
Cash Flow from Financing Activities	-1	3	0	0
Net Cash Inflow / Outflow	1	-1	-0	0
Closing Cash & Cash Equivalent	1	0	0	0

Amkay Products Ratios

#	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	4.91	2.31	2.41	4.13
CEPS(Rs)	5.36	3.15	3.53	5.01
DPS(Rs)	0	0	0	0
Book NAV/Share(Rs)	7.45	9.75	12.16	15.72
Core EBITDA Margin(%)	11.28	7.36	11.36	10.72
EBIT Margin(%)	10.79	6.69	10.2	12.95
Pre Tax Margin(%)	10.26	5.58	8.41	11.27
PAT Margin (%)	7.68	4.02	5.51	8.47
Cash Profit Margin (%)	8.38	5.49	8.05	10.25
ROA(%)	22.92	10.05	9.84	15.76
ROE(%)	65.98	26.81	22	29.65
ROCE(%)	71.91	29.32	24.73	28.84
Receivable days	36.68	38.62	48.07	45.19
Inventory Days	2.58	11.36	30.08	48.3
Payable days	82.74	72.85	71.04	41.54
PER(x)	0	0	0	0
Price/Book(x)	0	0	0	0
Dividend Yield(%)	0	0	0	0
EV/Net Sales(x)	0.02	0.12	0.18	0.38
EV/Core EBITDA(x)	0.15	1.48	1.39	2.56
Net Sales Growth(%)	0	-10.31	-23.67	11.5
EBIT Growth(%)	0	-44.4	16.45	41.56
PAT Growth(%)	0	-53.08	4.57	71.42
EPS Growth(%)	0	-53.08	4.57	71.44
Debt/Equity(x)	0.29	0.7	0.61	0.55
Current Ratio(x)	1.32	1.57	1.96	1.84
Quick Ratio(x)	1.28	1.24	1.38	0.99
Interest Cover(x)	20.54	6.02	5.7	7.7
Total Debt/Mcap(x)	0	0	0	0

Amkay Products Shareholding Pattern

#	Mar 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	73.44	73.44	73.44	73.44
FII	5.25	0.16	0	0
DII	6.28	0	0	0
Public	15.03	26.4	26.56	26.56
Others	0	0	0	0
Total	100	100	100	100

#	Mar 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	0.64	0.64	0.64	0.64
FII	0.05	0	0	0
DII	0.05	0	0	0
Public	0.13	0.23	0.23	0.23
Others	0	0	0	0
Total	0.87	0.87	0.87	0.87

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 26%
Debtor days have improved from 71.04 to 41.54days.
Company has reduced debt.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.